Ropes & Gray

CCMP Growth Advisors Announces Partnership With Innovative Refrigeration

Retrieved on: 
Thursday, January 11, 2024

CCMP Growth Advisors, LP (“CCMP Growth”) and Innovative Refrigeration Systems, Inc. (the “Company” or “Innovative”), a family-owned business which is a leader in design build engineering and aftermarket services for industrial refrigeration systems, today announced that CCMP Growth has partnered with Founder and CEO Mike McGinnis to invest in the Company and support its continued growth.

Key Points: 
  • CCMP Growth Advisors, LP (“CCMP Growth”) and Innovative Refrigeration Systems, Inc. (the “Company” or “Innovative”), a family-owned business which is a leader in design build engineering and aftermarket services for industrial refrigeration systems, today announced that CCMP Growth has partnered with Founder and CEO Mike McGinnis to invest in the Company and support its continued growth.
  • Tom Goeke, previously CEO of two legacy CCMP portfolio companies, will join the board and bring his expertise in building aftermarket service and software organizations to Innovative.
  • Mark McFadden, Co-Managing Partner of CCMP Growth, said, “Innovative is an outstanding, high growth business with a talented, dedicated management team, exactly the type of business with which CCMP Growth seeks to partner.
  • Current Capital Advisors, LLC acted as financial advisor and Ropes & Gray LLP acted as legal advisor to CCMP Growth.

Brogna joins FTNE as VP and Trust Officer

Retrieved on: 
Tuesday, January 9, 2024

Fiduciary Trust of New England (FTNE), a New Hampshire-chartered trust company serving individuals, financial advisors, and nonprofits, has recently welcomed Antonietta (Toni) Brogna, CTFA to the firm as Vice President and Trust Officer.

Key Points: 
  • Fiduciary Trust of New England (FTNE), a New Hampshire-chartered trust company serving individuals, financial advisors, and nonprofits, has recently welcomed Antonietta (Toni) Brogna, CTFA to the firm as Vice President and Trust Officer.
  • Brogna is based in FTNE’s Manchester, N.H. office, and reports to Fiduciary Trust of New England’s President & CEO Michael Costa, CFA .
  • View the full release here: https://www.businesswire.com/news/home/20240105356321/en/
    Antonietta (Toni) Brogna, VP and Trust Officer at Fiduciary Trust of New England (Photo: Business Wire)
    Brogna joins Fiduciary Trust from Goulston & Storrs, where she served as Director of Trust Administration for three years.
  • Prior to this role, she served as Director of Trust & Estate Services at Fletcher Tilton and as a Trust Advisor at Choate Hall & Stewart in Boston.

Praxis Precision Medicines Announces Licensing and Collaboration Agreement with Tenacia Biotechnology for Ulixacaltamide in Greater China

Retrieved on: 
Friday, January 5, 2024

BOSTON and SHANGHAI, Jan. 05, 2024 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced an exclusive collaboration and license agreement with Tenacia Biotechnology (Shanghai) Company, Ltd., a China-based clinical-stage biopharmaceutical company focused on CNS drug development and commercialization. Under the agreement, Tenacia will develop and commercialize ulixacaltamide for the treatment of essential tremor in Greater China, including mainland China, Hong Kong, Macau, and Taiwan.

Key Points: 
  • Under the agreement, Tenacia will develop and commercialize ulixacaltamide for the treatment of essential tremor in Greater China, including mainland China, Hong Kong, Macau, and Taiwan.
  • “Our collaboration with Tenacia is an important step to bringing the innovation of ulixacaltamide to essential tremor patients in China, where there is a significant unmet need,” said Marcio Souza, president and chief executive officer of Praxis.
  • We are excited to partner with Praxis to bring this innovative treatment to patients in Greater China,” said Xiaoxiang Chen, chief executive officer of Tenacia.
  • As part of the collaboration agreement, Praxis will receive $15 million up front, including $5 million in cash and a $10 million investment in Praxis common stock.

Joseph Guiliano appointed Chief IP Officer of Adeia

Retrieved on: 
Thursday, January 4, 2024

SAN JOSE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) today announced that Joseph Guiliano was appointed as Adeia’s chief intellectual property (IP) officer, after serving as outside legal counsel for Adeia’s IP portfolio since 1995.

Key Points: 
  • SAN JOSE, Calif., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Adeia Inc. (Nasdaq: ADEA) today announced that Joseph Guiliano was appointed as Adeia’s chief intellectual property (IP) officer, after serving as outside legal counsel for Adeia’s IP portfolio since 1995.
  • “With his nearly 30 years of experience with Adeia’s IP portfolio, Joe’s deep understanding of Adeia’s technologies will continue to be instrumental to the management and execution of our long-term portfolio strategy and revenue growth plans,” commented Paul E. Davis, chief executive officer of Adeia.
  • Prior to his appointment as Adeia’s chief IP officer, Guiliano served as the lead outside IP counsel for the media business of Adeia and its predecessor companies since 1995.
  • Prior to founding Haley Guiliano, he was the chair of the IP Rights Management practice at Ropes & Gray LLP.

Haley Guiliano, LLP Congratulates Joseph Guiliano, Co-Founder and Managing Partner, on His Transition to Chief IP Officer at Adeia

Retrieved on: 
Thursday, January 4, 2024

Effective January 1, 2024, Mr. Guiliano assumed the role of Chief IP Officer at Adeia Inc. ("Adeia"), a pioneering presence in the media and semiconductor industries.

Key Points: 
  • Effective January 1, 2024, Mr. Guiliano assumed the role of Chief IP Officer at Adeia Inc. ("Adeia"), a pioneering presence in the media and semiconductor industries.
  • Mr. Guiliano has represented Adeia for nearly his entire legal career.
  • Throughout his career in law firms, Mr. Guiliano's legal practice focused on developing IP strategies to deliver business-critical solutions to his clients.
  • I am immensely proud of my role in co-founding Haley Guiliano and am grateful for my time with the Firm.

Joseph Guiliano, Co-founder and Managing Partner at Haley Guiliano, LLP, Announces Transition to Chief IP Officer at Adeia

Retrieved on: 
Thursday, January 4, 2024

NEW YORK, Jan. 4, 2024 /PRNewswire/ -- After a renowned career spanning 30 years, Joseph Guiliano, the esteemed Co-founder and Managing Partner of Haley Guiliano, LLP, is retiring from the practice of law. Effective January 1, 2024, Mr. Guiliano will step into a new chapter as he assumes the role of Chief IP Officer at Adeia, a pioneering presence in the media space.

Key Points: 
  • Effective January 1, 2024, Mr. Guiliano will step into a new chapter as he assumes the role of Chief IP Officer at Adeia, a pioneering presence in the media space.
  • Joe's legal career is characterized by proactive strategies and foresight that lead to innovative business-centered solutions.
  • I am immensely proud of my role at Haley Guiliano, and I am grateful for my time with the firm.
  • As Joe embarks on this exciting new chapter, the HG team extends their warmest wishes for his continued success.

McNally Capital to Sell Advanced Micro Instruments, Inc. to Enpro Inc.

Retrieved on: 
Wednesday, January 3, 2024

McNally Capital (“McNally”), a private equity firm, is pleased to announce the firm has entered into a signed purchase agreement for the sale of Advanced Micro Instruments, Inc. (“AMI” or the “Company”) to Enpro Inc. (NYSE: NPO).

Key Points: 
  • McNally Capital (“McNally”), a private equity firm, is pleased to announce the firm has entered into a signed purchase agreement for the sale of Advanced Micro Instruments, Inc. (“AMI” or the “Company”) to Enpro Inc. (NYSE: NPO).
  • McNally invested in AMI in partnership with the company’s founder, Steven Kirchnavy, in 2014.
  • We look forward to continuing our growth trajectory by joining the Enpro family,” said Kevin Bates, President and CEO of AMI.
  • The firm is currently investing out of its committed buyout fund, McNally Capital Fund II, LP.

Golden Gate Capital Partners With Founder and CEO Gil Grattan on Recapitalization of Virginia Green

Retrieved on: 
Wednesday, January 3, 2024

Golden Gate Capital, a San Francisco-based private equity firm, in partnership with Founder and CEO Gil Grattan, today announced the recapitalization of Virginia Green (“the Company”), the leading provider of lawn care in Virginia.

Key Points: 
  • Golden Gate Capital, a San Francisco-based private equity firm, in partnership with Founder and CEO Gil Grattan, today announced the recapitalization of Virginia Green (“the Company”), the leading provider of lawn care in Virginia.
  • Mr. Grattan will continue to lead the Company as CEO and will remain a significant shareholder.
  • Founded in 2004, Virginia Green is a premier operator of residential lawn treatment services with a growing footprint of ten locations and 70,000 customers across key local markets.
  • TD Cowen served as financial advisor and Paul, Weiss, Rifkind, Wharton & Garrison LLP and Ropes & Gray LLP served as legal advisors to Golden Gate Capital.

Biora Therapeutics Accelerates Debt Reduction and Raises Capital with Large Institutional Investors

Retrieved on: 
Monday, December 18, 2023

SAN DIEGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced an agreement with institutional investors Athyrium Capital Management, Davidson Kempner Capital Management, and Highbridge Capital Management to reduce the company’s net debt by 60% through a convertible note exchange which also brings $16.7 million in new capital.

Key Points: 
  • SAN DIEGO, Dec. 18, 2023 (GLOBE NEWSWIRE) -- Biora Therapeutics, Inc. (Nasdaq: BIOR), the biotech company that is reimagining therapeutic delivery, today announced an agreement with institutional investors Athyrium Capital Management, Davidson Kempner Capital Management, and Highbridge Capital Management to reduce the company’s net debt by 60% through a convertible note exchange which also brings $16.7 million in new capital.
  • Between the note exchange implemented in September and today’s transaction, we achieved a 75% overall reduction in net debt.
  • This represents substantial progress toward our goal to optimize our capital structure to align with the current company profile,” said Eric d’Esparbes, Chief Financial Officer of Biora Therapeutics.
  • “The additional capital investment from three established institutional investors demonstrates continued support for our innovative technologies.

Monomoy Capital Partners to Acquire Leading Global Iron Casting Supplier Waupaca Foundry

Retrieved on: 
Thursday, December 21, 2023

Proterial, Ltd. (“Proterial”), a leading international producer of high-performance materials for mobility, industrial infrastructure, and electronics, today announced the signing of a definitive agreement for Monomoy Capital Partners (“Monomoy”) to acquire Waupaca Foundry, Inc. (“Waupaca Foundry” or the “Company”), North America’s leading supplier of cast and machined iron castings.

Key Points: 
  • Proterial, Ltd. (“Proterial”), a leading international producer of high-performance materials for mobility, industrial infrastructure, and electronics, today announced the signing of a definitive agreement for Monomoy Capital Partners (“Monomoy”) to acquire Waupaca Foundry, Inc. (“Waupaca Foundry” or the “Company”), North America’s leading supplier of cast and machined iron castings.
  • Waupaca Foundry will continue to operate under its current management team, led by President, CEO, and COO Michael Nikolai.
  • Waupaca Foundry is the leading supplier of cast and machined iron castings for automotive, commercial vehicle, agriculture, construction, and other industrial markets.
  • JPMorgan Securities LLC and Moelis & Company LLC served as financial advisors, and Ropes & Gray LLP served as legal counsel to Waupaca Foundry.